View Author
Tol, M.J. van
( M.J. van Tol)
antibody rabie response vaccination patient immunization anti-rabie study vaccine diabetes population gad antibodies booster index gad index concentration individual fi ve patients booster vaccination adult 4 weeks igg 1 immunode ficiency rabies vaccine avidity immunode ficiency neoantigen humoral serum gad antibody concentrations result t-cell rabies vaccination igg subclasses virus threshold proliferative response booster immunization immunol month antigen reference avidity maturation titer range proliferative schoolchildren netherland proliferation signi group effect immunology ### epilepsy neoantigen rabies fi rst vaccination subclasse frequency *** iu /ml diabetes mellitus correlation disease 1012-joci december value journal increase joci.cl acid decarboxylase time-point rabies virus stimulation t test 37◦ c culture diploid avidity index
2 Most Recent Publications
|
Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man
(Article)
Brinkman, D.M. Dam, M.M. ten Vossen, J.M.J.J. Osterhaus, A.D.M.E. Kroon, F.P. Tol, M.J. van Jol-van der Zijde, C.M. |
2003-01-01
|
|
Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values
(Article)
Batstra, M.R. Driel, A. van Petersen, J.S. Donselaar, C.A. van Tol, M.J. van Bruining, G.J. Grobbee, D.E. Dyrberg, T. Aanstoot, H.J. |
1999-01-01
|
